# Amisulpride Treatment for BPSD in AD Patients

> **NCT04341467** · NA · UNKNOWN · sponsor: **Tianjin Anding Hospital** · enrollment: 76 (estimated)

## Conditions studied

- BPSD
- Amisulpride
- Olanzapine
- Dementia of the Alzheimer Type

## Interventions

- **DRUG:** Amisulpride
- **DRUG:** Olanzapine

## Key facts

- **NCT ID:** NCT04341467
- **Lead sponsor:** Tianjin Anding Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-05
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2022-11-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04341467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04341467, "Amisulpride Treatment for BPSD in AD Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04341467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*